The Lin-Zhi International (LZI) Buprenorphine Enzyme Immunoassay is intended for the qualitative and semi-quantitative determination of norbuprenorphine (a buprenorphine metabolite) in human urine at a cutoff value of 5 ng/mL and 10 ng/mL
The assay is designed for prescription use with a number of automated clinical chemistry analyzers
The LZI buprenorphine assay is a homogeneous enzyme immunoassay using a ready-to-use liquid reagent
